Crossmark

Artificial liver support with Cytosorb and continuous veno-venous hemodiafiltration versus advanced organ support (ADVOS) for critically ill patients with hyperbilirubinemia and acute-on-chronic liver failure (ACLF)

Crossref DOI link: https://doi.org/10.1186/s12882-025-04342-6

Published Online: 2025-08-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Schönfelder, Kristina

Hirsch, Luisa Katharina

Kribben, Andreas

Jahn, Michael

Tyczynski, Bartosz

Friebus-Kardash, Justa
Funding

Funding for this research was provided by:

Universitätsklinikum Essen
License Information

Text and Data Mining valid from 2025-08-04

Version of Record valid from 2025-08-04
More Information

Article History

Received: 10 March 2025

Accepted: 15 July 2025

First Online: 4 August 2025

Declarations

:

: The study was conducted according to the guidelines of the Declaration of Helsinki and was approved by the Ethics Committee of the University Hospital Essen (23-11563-BO, 23-11170-BO). The consent to participate was waived by the local ethics committee of the University Duisburg-Essen (23-11563-BO, 23-11170-BO) due to the retrospective analyses that deal with data obtained from clinical routine.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below